Italian Medicines Agency Agenzia Italiana del Farmaco

Vaxzevria Vaccine (ex Covid-19 Vaccine AstraZeneca)

Vaxzevria Vaccine (ex COVID-19 Vaccine AstraZeneca)

Vaxzevria Vaccine is used to prevent coronavirus disease 2019 (COVID-19) in people from 18 years of age. It has been designed to prepare the immune system to identify and combat the coronavirus SARS-CoV-2 causing COVID-19.

The vaccine is made up of a chimpanzee adenovirus (ChAdOx1 - Chimpanzee Adenovirus Oxford 1) that is unable to replicate and that has been modified to contain the genetic information for producing the SARS-CoV-2 spike protein.

The viral vector technology used for this vaccine has already been successfully tested and has been employed in the prevention of other diseases.

Nested Applications

Last tweets

Go to Twitter profile

Multimedia

ABC della Ricerca Clinica - Perché la randomizzazione è essenziale?

Go to YouTube channel

go to beginning of content